March 28 (Reuters) - Milestone Pharmaceuticals (MIST.O), opens new tab said on Friday the U.S. health regulator had declined to approve its nasal spray to treat a type of heart condition and had ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback